We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current RTNXF market cap is 53.38M. The company's latest EPS is USD -0.1003 and P/E is -0.75.
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 339k | 1.49M | 2.97M | 3.4M | 2.29M |
| Operating Income | -10.8M | -34.72M | -57.24M | -32.19M | -29.36M |
| Net Income | -9.25M | -31.01M | -56.73M | -46.22M | -33.46M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 41.3M | 102.58M | 63.26M | 42.12M | 7.97M |
| Total Liabilities | 5.34M | 7.48M | 20.09M | 23.66M | 15.83M |
| Total Equity | 35.96M | 95.1M | 43.17M | 18.45M | -7.85M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -10.06M | -24.63M | -45.75M | -32.67M | -30.11M |
| Investing | -849k | -741k | -694k | N/A | -4k |
| Financing | 16.85M | 77.24M | 25.52M | 15.12M | 10.25M |
| Market Cap | 53.38M |
| Price to Earnings Ratio | -0.75 |
| Price to Sales Ratio | 10.87 |
| Price to Cash Ratio | 5.36 |
| Price to Book Ratio | -3.19 |
| Dividend Yield | - |
| Shares Outstanding | 333.64M |
| Average Volume (1 week) | 2.5k |
| Average Volume (1 Month) | 2.5k |
| 52 Week Change | 3.83% |
| 52 Week High | 0.641 |
| 52 Week Low | 0.15 |
| Spread (Intraday) | 900.11 (100%) |
| Company Name | Renalytix PLC (PK) |
| Address |
2 leman street london E1W 9US |
| Website | https://renalytix.com |
| Industry | services, nec (8999) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
